Yaacov-Garbeli Dana 4
4 · Entera Bio Ltd. · Filed Apr 25, 2023
Insider Transaction Report
Form 4
Entera Bio Ltd.ENTX
Yaacov-Garbeli Dana
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-04-24+190,000→ 190,000 totalExercise: $0.80Exp: 2033-04-24→ Ordinary Shares, par value NIS 0.0000769 per share (190,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period with 25% of the options vesting on April 24, 2024, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.